Thyroid-stimulating hormone (TSH)-armed polymer-lipid nanoparticles for the targeted delivery of cisplatin in thyroid cancers: therapeutic efficacy evaluation
Thyroid-stimulating hormone (TSH)-conjugated polymer-lipid hybrid nanoparticles (TPLHC) were developed for the targeted delivery of cisplatin (CDDP) in thyroid cancers. In the present study, polymer-lipid hybrid nanoparticles were conjugated to TSH, which will bind to the TSH receptor (TSHr) on the...
Gespeichert in:
Veröffentlicht in: | RSC advances 2015-01, Vol.5 (129), p.16413-1642 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!